Monoclonal
antibodies were produced against phosphateactivated glutaminase (EC 3.5.1.2) as a marker for glutamatergic neurons:
The enzyme was purified lOOO-fold from rat brain mitochondria with a recovery of 27%. Upon SDS-PAGE the purified enzyme showed a single band up to 1.7 pg after the silver staining at molecular weight 62,000. Two monoclonal antibodies (IgMs) were produced; these absorbed more than 90% of glutaminase activity in rat brain homogenate.
In immunoblotting after PAGE of the homogenate, the antibodies recognized only 1 protein band at the same position as that of the purified enzyme.
Thus, the antibodies are specific and sufficient markers for glutaminase. Many neuronal cells in the rat brain were labeled immunohistochemically with these antibodies, but non-neuronal elements such as glial cells and vessels were not. Intense labeling was consistently observed in putative glutamatergic neurons such as pyramidal cells of layers V and VI in the cerebral neocortex. Intense staining was also seen in possible mossy fiber endings in the granular layer of the cerebellar cortex and in neurons giving off mossy fibers such as those in the pontine nuclei, pontine tegmental reticular nucleus of Bechterew, lateral reticular nucleus of the medulla oblongata, and external cuneate nucleus.
L-Glutamate is assumed to be one of the major excitatory neurotransmitters in the mammalian CNS, and the regional distribution of glutamatergic neurons in the brain has been studied by measuring content, release, and uptake of glutamate (for reviews, Watkins and Evans, 198 1; Fonnum, 1984) or by autoradiography of L-glutamate binding sites (Greenamyre et al., 1984; Halpain et al., 1984) . Recently, Otterson and StormMathisen (1984) raised antisera against glutamate conjugated to BSA and demonstrated glutamate-like immunoreactivity in pyramidal cells in the cerebral neocortex and other neurons in mouse and rat brains. According to these authors, however, the immunoreactivity reveals the "metabolic pool" as well as the "transmitter pool" ofglutamate in the brain. Therefore, a specific marker for the transmitter pool of glutamate is necessary to identify glutamatergic neurons.
Since the transmitter pool of glutamate is mainly supplied from glutamine (Bradford et al., 1978 (Bradford et al., , 1983 Reubi et al., 1978; Hamberger et al., 1979a, b; Reubi, 1980) , glutamatergic neurons are expected to contain glutaminase, which catalyzes the hydrolytic cleavage of L-glutamine to form L-glutamate and ammonium ions. Therefore, phosphate-activated glutaminase (PAG, L-glutamine amidohydrolase, EC 3.5.1.2), a main isozyme of glutaminase in the brain (Kvamme, 1983 ) is a good marker for glutamatergic neurons. Recently, Altshuler et al. (1984) reported the presence of PAG-like immunoreactivity in the auditory nerve using an antiserum raised against the glutaminase of the rat kidney. In their study, the glutaminase immunoprecipitated with the antiserum showed some heterogeneity on SDS-PAGE. Although they ascribed the heterogeneity to the proteolytic degradation of the enzyme, it may result from the lower specificity of the polyclonal antiserum. To avoid this possibility, an attempt was made to prepare monoclonal antibodies against brain PAG. We purified PAG from rat brain, produced monoclonal antibodies against the enzyme, and then applied them to immunohistochemical staining.
Materials
and Methods
Enzyme assay
The assay mixture contained 15 mM boric acid, 250 mM potassium phosphate (pH 8.0) , and enzyme in a total volume of 50 ~1 except as noted. After preincubation at 25°C for 30 min, the reaction was started by the addition of 14C(U)-L-glutamine (0.12 r.0) at a final concentration of 15 mM and incubated at 25°C for 3 min. The incubation was terminated by the addition of 50 ~1 of ice-cold ethanol. The glutamic acid formed was separated from glutamine by the method of Prusiner and Milner (1970) . Briefly, the solution was mixed with 0.9 ml of 200 mM acetate-NaOH (pH 4.5) and applied to a 5.5 x 10 mm Dowex l-X8 (analytical grade, acetate form, 200-400 mesh) column. The column was washed with 6 ml of distilled water to remove glutamine, and glutamic acid was then eluted with 2 ml of 1 N HCl. The radioactivitv of the eluate was determined by Beckman scintillation counter mode? LS 2800. In some cases, the reaction products were separated by thinlayer cellulose chromatography in 2-propanol/formic acid/water (40:2: 10, vol/vol) as described by Niederwieser (1972) to identify the product as glutamic acid (Niederwieser, 1972) . One unit (U) is defined as the amount of enzyme that catalyzes the production of 1 pmol glutamic acidmin. Protein was estimated by the method of Lowry et al. (195 1) using BSA as a standard.
Solubilization and purljication of PAG
The mitochondrial fraction was chosen for the starting material because PAG was localized principally in mitochondria (Salganicoff and De Robertis, 1965; Neidle et al., 1969) . All steps were carried out at 0-4°C except as noted.
Step I: Preparation of rat brain mitochondria. Wistar rats g body weight) were sacrificed by decapitation under anesthesia. Brains (140 g) were quickly removed, collected on ice, and homogenized in 6 vol of 0.32 M sucrose containing 5 mM potassium phosphate (pH 8.0) by using a Potter-Elvehjem glass homogenizer with a Teflon pestle. The homogenate was centrifuged at 1000 x g for 20 min. The nuclear pellet was resuspended with 4 vol of the same solution and centrifuged again. The supernatants were combined and then centrifuged at 10,000 x g for 30 min. The crude mitochondrial pellet was resuspended in 50 mM Tris-HCl (pH 8.0) containing 1 mM EDTA and 6.4 mM 2-mercaptoethanol (T buffer) to a final volume of 140 ml and stored at -80°C until used.
Step 2: Solubilization. PAG was solubilized with Triton X-100 as described for the renal enzyme (Curthoys et al., 1976) . The crude mitochondria were thawed and homogenized in T buffer containing 1% Triton X-100. The protein concentration was adjusted in the range of 5-10 mg/ml. After incubation for 30 min, the suspension was centrifuged at 90,000 x g for 60 min and the supematant recovered.
Step 3: First sodium sulfate fractionation. This step was carried out at room temperature. One and a half volumes of 2 M Na,SO, in distilled water was added to the supematant and stirred for 30 min. After centrifugation at 17,700 x g for 30 min, floating cakes were collected by siphoning off and resuspended in T buffer to 5-10 mg protein/ml. Sodium sulfate (2 M in distilled water) was added again to the suspension to give a final concentration of 0.6 M, stirred for 30 min, and centrifuged at 17,700 x g for 30 min. The infranatant was collected by siphoning off, and sodium sulfate (2 M in distilled water) was added to give a final concentration of 1 M. The mixture was stirred and centrifuged at 17,700 x g for 30 min. The precipitate was resuspended in 15 ml of T buffer containing 1% Triton X-100 to prevent PAG from aggregating and was dialyzed overnight against 3 changes of 2 liters of T buffer at 4°C.
Step 4: First gelfiltration. After centrifugation at 20,000 x g for 30 min to remove insoluble materials, the sample was applied to a-column (5 x 45 cm) of Seohacrvl S-400 eauilibrated in T buffer. The flow rate was240 mb'hr. --Step 5: Lysine-Sepharose chromatography. The active fractions obtained from Step 4 were pooled and applied to a column (1.5 x 11.5 cm) of 1ysineSepharose equilibrated in T buffer, at a flow rate of 48 ml/hr. After the column was washed with 150 ml of T buffer, adsorbed proteins were eluted with 0.5 M potassium phosphate (pH 8.0) at a flow rate of 32 ml/hr. Triton X-100 molecules of free form were removed from the sample at this step.
Step 6: Second sodium sulfate fractionation. The eluate was incubated with 15 mM boric acid-NaOH (oH 8.0) at 25°C for 30 min to uolvmerize PAG (Nimmo and Tipton, 1980) , andthen 1.5 vol of 2 M sod& sulfate in distilled water was added to the eluate. After incubation at 25°C for 30 min, the mixture was centrifuged at 20,000 x g for 30 min. The pellet was resuspended in 3 ml of 0.5 M potassium phosphate (pH 8.0), 15 mM boric acid, 1 mM EDTA, and 6.4 mM 2-mercaptoethanol (PB buffer), and centrifuged at 1300 x g for 5 min to remove insoluble materials.
Step 7: Secondgelfzltration. The supematant was applied to a column (2.5 x 40 cm) of Sepharose 4B equilibrated in PB buffer. The flow rate was 50 ml/hr.
Step 8: Centrijkgation. The active fractions were pooled and centrifuged at 27 1,000 x g for 4 hr. The precipitate was resuspended in 2 ml of 50 mM Tris-acetate (pH 8.0), 1 mM EDTA, and 6.4 mM 2-mercap- toethanol, and dialyzed overnight against 2 changes of 1 liter of the same buffer. The solution was centrifuged at 100,000 x g for 30 min, and the pellet was discarded. The final sample was stored at -80°C until employed for immunization.
Production of monoclonal antibodies
Monoclonal antibodies were produced by the method of Kijhler and Milstein (1975) . Emulsion of purified PAG (30 pg) and complete Freund's adjuvant was injected intraperitoneally to a BALBlc mouse. Three weeks after the immunization, a booster shot (30 pg PAG) in incomplete Freund's adjuvant was inoculated. Four weeks after the booster, an intravenous boost with 10 pg of PAG in 0.2 ml of saline was carried out. The mouse was sacrificed 3 days after the final injection, and then spleen cells (5 x lo*) were fused with 2.5 x lo* myeloma cells P3-NSl/ 1 -Ag4-1 (a generous gift from Dr. Y. Nishikawa, Faculty of Medicine, Kyoto University) by the addition of 2 ml of 50% (wt/vol) polyethylene glycol4000. The resulting cell suspension of hybrid was inoculated into three 96-well microtiter plates and fed with selective HAT medium containing 10% fetal calf serum, 2 mM L-glutamine, 50 PM 2-mercaptoethanol, 0.1 mM hypoxanthine, 0.4 PM aminopterin, and 16 PM thymidine in RPM1 1640 medium. Cultures showing hybrid growth were screened for production of anti-PAG antibodies as described below. Positive cells were cloned at least twice by a limiting dilution method.
Detection of anti-PAG antibodies
A small round nitrocellulose membrane (6 mm in diameter) was dotted with 1 pl of purified PAG (30 &ml) and dried up. The dotted disk was immunostained by the method of Hsu et al. (198 1) . In a well of a 96-well microtiter plate, the membrane was incubated in the following order: (1) with 0.1 ml of PBS containing 10% normal horse serum for 30 min, (2) with 50 ~1 of culture fluid for 60 min, (3) with 0.1 ml of 27 &ml biotinylated anti-[mouse IgG (H+L)] Ig, which had 35% crossreactivity with mouse IgM, in PBS containing 0.3% Triton X-100 (PBS-X) for 3d min, (4) with 0.1 ml of avidin-biotinylated peroxidase complex (ABC: Vectastain ABC kit) in PBS-X for 30 min. and (5) with 0.02% (w&l) 3,3'-diaminobenzidine tetrahydrochloride and 6.0045% hydrogen peroxide in 50 mM Tris-HCl (pH 7.6) (Graham and Kamovski, 1966) for 5 min. All incubations were carried out at room temperature and the membrane was rinsed with PBS-X after each incubation. 
Typing and purification of antibodies
Immunoglobulin classes of monoclonal antibodies were identified by using mouse and rat monoclonal typing kits (Serotec) with the Ouchterlony immunodiffusion technique. Ascites tumors were induced by injecting 1 x 10' hybridoma cells into Pristane-primed BALB/c mice intraperitoneally.
In order to purify mouse IgM from ascites and culture medium, euglobulin precipitation and gel filtration were employed (Johnstone and Thorpe, 1982).
Immunotitration
The rat brain was homogenized in 10 vol of T buffer containing 1% Triton X-100 and centrifuged at 100,000 x g at 4°C for 1 hr. Various amounts of antibody or control mouse IgM were added to 100 ~1 of the supematant containing 77 mU of PAG and stirred at 4°C for 1 hr. After the incubation, 72 ~1 of concanavalin A (Con A)-Sepharose gel was added to the mixture and stirred again at 4°C for 1 hr to trap IgM (Weinstein et al., 1972) . After centrifugation at 8000 x g for 10 min, the supematant was recovered for PAG assay.
PAGE and immunoblotting
PAGE in the presence of 0.1% SDS was carried out by the method of Laemmli (1970) . Protein was stained with silver using a commercial kit of Silver Stain Kanto (Kant0 reagents, Tokyo, Japan). For the immunoblotting test, the rat brain was homogenized in 10 vol of 62.5 mM Tris-HCl (PH 6.8) containing 1% Triton X-100 and centrifuged at 100,000 x g at 4°C for 1 hr. The supematant or purified PAG was applied to 7.5% PAGE in the presence of 0.1% Triton-X 100 by using the discontinous buffer system of Davis (1964) or in the presence of SDS as described above. After electrophoresis, proteins were transferred from the gel to Zeta-Probe membrane in 25 mM Tris-192 mM glycine (pH 8.3) by electrophoresis at 60 V for 3 hr at 4°C. After the blockina treatment with 16% normal goat serum in PBS at least for 1 hr, the-membrane strips cut from the blot (about 4 mm wide) were incubated overnight with 10 &ml monoclonal antibody or mouse myeloma IgM in PBS-X containing 10% normal goat serum. After being washed, the strips were immunostained by the unlabeled antibody peroxidase-antiperoxidase (PAP) method of Stemberaer (1979) with rabbit anti-(mouse IaM) IaG diluted l/100, goat anti-(rabbit I&) serum diluted 'l/50, anld rabrbit PAP diluted l/200. All incubations were performed in PBS-X for 1 hr at room temperature and the blots were rinsed with PBS-X after each incubation. Bound peroxidase was stained with Graham-Kamovski's solution as mentioned above.
Immunohistochemistry
Wistar rats (200-350 g) were anesthetized with sodium pentobarbital (100 mg/kg body weight, i.p.) and perfused transcardially with 200 ml of Krebs-Ringer solution, followed by 200 ml of modified Zamboni's solution (2% paraformaldehyde and 75% saturated picric acid in 0.1 M sodium phosphate, pH 7.2) for 30 min at room temperature. The brains were quickly removed, cut into several blocks, and placed in the same buffer at 4°C for 4 hr. After rinsina in ice-cold PBS containine 10% and then 20% sucrose, the blocks werefrozen on dry ice and cut iito frontal sections 40 pm thick. The sections were collected in PBS and immunostained by the ABC method (Hsu et al., 198 1) . The incubation steps were as follows: (1) 10% normal goat serum for 1 hr; (2) monoclonal antibody (10 &ml in PBS-X) overnight at 4°C in the absence or presence of excess nurified PAG (170 &ml): (3) biotinvlated anti-(mouse IgM) Ig (2.3 &'ml) for 1 hr; and (4 ABC'for 1 hr.-Steps (1) (j), and (4) were carried out in PBS-X at room temperature, and the sections were rinsed with PBS-X after each incubation. The peroxidase was visualized by the incubation at room temperature for 30-60 min with Graham-Kamovski's solution. In several animals, fixation was performed with Bouin's solution, 2-8% paraformaldehyde solution (pH 7), 2% paraformaldehyde solution (pH 7) containing 2% carbodiimide, or 0.2-2% glutaraldehyde. Of fixatives used in the present study, the modified Zamboni's solution gave the best result in immunostaining for PAG.
Materials t+C(U)-glutamine (> 200 mCi/mmol) and L-glutamine were purchased from New England Nuclear and Nakarai Chemicals, Kyoto, Japan, respectively. Before use, both were purified by passage through Dowex 1 -X8 (acetate form) columns to remove glutamic acid. The sources of other materials used in this work were as follows: Sephacryl S-400, lysin+Sepharose, Sepharose 4B, and Con A-Sepharose from Pharmacia; nitrocellulose and Zeta-Probe membranes, and Dowex l-X8 resin from Bio-Rad; complete and incomplete Freund's adjuvants from Difco: polvethvlene dvcol 4000 from Merck: RPM1 1640 medium from 
Results

Purijication of PAG
Purification of rat brain PAG is summarized in Table 1 . About 70% of PAG activity in the crude homogenate was recovered in the mitochondrial fraction. The specific activity in the mitochondrial fraction (0.17 U/mg protein) was about 3-fold higher than that of the homogenate.
PAG was solubilized from the crude mitochondrial fraction by using 1% Triton X-100 with slight activation (108%). The remaining pellet had less than 1% ofthe initial activity. In the gel-filtration step on Sephacryl S-400 in T buffer, the elution peak of PAG activity was retarded by about % the bed volume from the void volume of the column.
When the enzyme was incubated with phosphate and borate, it polymerized and was eluted in the void volume of gel filtration with Sepharose 4B in PB buffer. These properties of PAG were similar to those described in the purification of PAG from rat kidney (Curthoys et al., 1976) and pig brain (Nimmo and Tipton, 1980) . In the final step, PAG was purified lOOO-fold from the mitocondrial fraction with a recovery of 27%, and about 3000-fold from the crude brain homogenate. The specific activity of the purified enzyme was 174 U/mg protein in the presence of 250 mM potassium phosphate and 15 mM boric acid, 168 in the presence of 250 mM potassium phosphate without borate. In the absence of both phosphate and borate, the purified enzyme was almost inactive (< 1 U/mg protein). The reaction product catalyzed by the purified enzyme exhibited the same mobility as that of glutamic acid on thin-layer chromatography. Thus, a b C FL.!.,.\ e I f the purified enzyme showed the properties essential to phosphate-activated glutaminase.
In the presence of 250 mM phosphate and the absence of borate, the K,,, value for glutamine and pH optimum were 5.0 mM and 8.7, respectively. The purity of the preparation was checked by SDS-gel electrophoresis (Fig. 1) . Only one band of protein was detected at the molecular weight 62,000 position.
Monoclonal antibodies
After 3 weeks of selection in HAT medium, 36% of the wells contained growing hybridomas. Out of 14 wells positive for anti-PAG activity, 9 wells survived repetitive cloning. All cell lines secreted IgM. Two antibodies (mAb-19 and -21) purified from ascites fluids and/or culture media were used in the following experiments.
Immunotitrations of rat brain PAG with the antibodies are shown in Figure 2 . PAG activity in the homogenate of the whole brain was completely extracted with 1% Triton X-100. The activity of the extract was absorbed with both antibodies, mAb-19 and -2 1, in a dose-dependent manner. The absorption activity of mAb-2 1 was a little higher than that of mAb-19. After incubation with an excess amount of the antibodies, PAG activity decreased to less than 10% of the initial activity. Therefore, these antibodies recognized at least 90% of PAG activity in the brain. When the crude extract was incubated with control mouse IgM, the enzyme activity in the supernatant was not absorbed.
Immunoblotting after 7.5% PAGE in the presence of 0.1% Triton X-100 revealed the specificity of both the antibodies (Fig.  3) . Among many bands of protein in the Triton X-100 extract of the whole brain (lane a), mAb-19 and -21 recognized only 1 band (lanes e, d) at the same position as that of the purified enzyme (lanes b, c) . In lane c, a weakly positive band is seen above the intensely stained band, which probably resulted from the tendency ofthe purified enzyme to polymerize, as mentioned by Nimmo and Tipton (1980) . The finding in lanes d and e means not only that the antibodies were specific for PAG, but also that PAG in the crude Triton X-100 extract had no heterogeneity on gel electrophoresis in the presence of Triton X-100. No positive band was detected in immunoblotting after SDSgel electrophoresis, suggesting that the enzyme lost the immu--Origin noreactivity with the antibodies in the presence of SDS. The results of immunoblotting and immunotitration tests indicated that the 2 antibodies, mAb-19 and -21, were specific and sufficient markers for PAG in the rat brain.
Immunocytochemical application of monoclonal antibodies Immunohistochemical applicability of mAb-19 and -21 was examined using the cerebral neocortex of the rat, since there is a growing body of evidence indicating that at least some pyramidal cells in the neocortex are glutamatergic (Watkins and Evans, 1981; Fonnum, 1984; Donoghue et al., 1985) . Many pyramidal cells were intensely labeled with mAb-2 1 in layer V, moderately in layer VI, and slightly in the supragranular layer (Fig. 4a) . The immunoreactivity of mAb-19 (Fig. 4b) was lower than that of mAb-21 (Fig. 4c) , as expected from the results of the immunotitration (Fig. 2) . When the antibody was reacted with an excess amount of purified PAG (> 170 &ml) before incubation, no immunoreactive products were observed (Fig.   4d ).
Immunohistochemical analysis with the antibody mAb-2 1 revealed that PAG-like immunoreactivity (PAG-LI) was observed in many neurons but not in glial cells or vessels in the rat brain. Neurons with intense PAG-LI were seen in the pontine nuclei, pontine tegmental reticular nucleus of Bechterew, lateral reticular nucleus of the medulla oblongata, and external cuneate nucleus (Fig. 5, a-a') , as well as in layers V and VI of the cerebral neocortex. Possible axon terminals with PAG-LI were observed in the cerebellum and inferior olive: Small clusters of immunoreactive grains were scattered in the granular layer of the cerebellum (Fig. 5e) . Immunoreactive fine grains were also distributed densely throughout the whole extent of the inferior olivary complex (Fig. 5f ). No cell bodies, however, were labeled for PAG-LI in the inferior olivary complex.
Discussion
Phosphate-activated glutaminase has been purified from pig kidney (Kvamme et al., 1970) , pig brain (Svenneby et al., 1973; Nimmo and Tipton, 1980) , and rat kidney (Curthoys et al., 1976) , but not from rat brain. We reported here the purification of solubilized PAG from rat brain mitochondria. Solubilization with Triton X-100 was a good extraction method (a yield of 108%); this resulted in the highest yield (19% from the homogproperty of polymerization in the presence of phosphate and enate) of the purification. On SDS-PAGE glutaminases purified borate and had a pH optimum in the range of 8.7-9.0. from the kidney showed some heterogeneity (Kvamme et al., As expected from the fact that PAG, the antigen, was extracted 1970; Shapiro et al., 1978) , whereas brain enzymes were apfrom the mitochondria with 1% Triton X-100, the preincubaparently homogeneous at molecular weights 63,900 (Svenneby tion of the sections with 1% Triton X-100 before immunoet al., 1973), 73,000 (Nimmo and Tipton, 1980) , and 62,000 staining led to the weakening of the immunoreactivity. On the (present study). Both the brain and kidney enzymes showed the other hand, if the sections were incubated with the antibodies Figure 5 . PAG-like immunoreactivity in the precerebellar nuclei and cerebellar cortex. Intensely labeled neuronal somata are seen in the pontine tegmental reticular nucleus of Bechterew (a), pontine nuclei (b), external cuneate nucleus (c), and lateral reticular nucleus of the medulla oblongata (d). Small clusters of grains, possible axon terminals, with PAG-LI are seen in the granular layer of the cerebellar cortex (e). Fine grains with PAG-LI are densely distributed, but no cell bodies are seen in the inferior olivary nucleus cf). CM, cerebellar medulla; G, granular layer; M, molecular layer; ML, medial lemniscus; P, pontine longitudinal fibers; Py, pyramidal tract; R, raphe. Scale bar, 200 pm (u-d, f) or 50 am (e).
in the absence of Triton X-100, no immunoreactivity was observed, probably because of the inaccessibility of the IgMs to PAG in the mitochondria. The best immunostaining for PAG was obtained when 0.3% Triton X-100 was included in the incubation media.
The immunohistochemical experiments showed that pyramidal cells were intensely labeled with the monoclonal antibodies in layer V and moderately in layer VI of the cerebral neocortex of the rat. This result is consistent with the recent immunohistochemical study with the antiserum against rat renal PAG (Donoghue et al., 1985) , and it supports the notion that some pyramidal cells in layers V and VI of the cerebral neocortex use glutamate as neurotransmitter (for reviews, Watkins and Evans, 1981; Fonnum, 1984; Donoghue et al., 1985) .
Afferent fibers to the cerebellar cortex as generally divided into 3 categories; the first are climbing fibers, which originate from the inferior olivary complex to mediate excitatory inputs to Purkinje cells; the second are mossy fibers, which arise from the precerebellar nuclei other than the inferior olive to convey excitatory inputs to granule cells; and the last are monoaminergic afferents, which comprise noradrenergic fibers from the locus coeruleus and serotonergic fibers from the raphe nuclei (Eccles et al., 1967; Brodal, 198 1; Ito, 1984) . Climbing fibers originating from the inferior olive appear to contain aspartate as transmitter (Wiklund et al., 1982; Campistron et al., 1986) . Although some mossy fibers have been reported to contain choline acetyltransferase (Kan et al., 1978) , substance P (Inagaki et al., 1982a) , or somatostatin (Inagaki et al., 1982b) , candidate transmitters for the vast majority of mossy fibers are still unknown (Ito, 1984) . The present study showed that small clusters of possible axon terminals with high PAG-LI were scattered in the granular layer of the cerebellar cortex and that many neuronal cell bodies with high PAG-LI existed in the pontine nuclei, pontine tegmental reticular nucleus of Bechterew, lateral reticular nucleus of the medulla oblongata, and external cuneate nucleus. All of these lower brain-stem nuclei are precerebellar nuclei sending mossy fibers to the cerebellar cortex (Eccles et al., 1967; Brodal, 198 1; Ito, 1984) . Thus, the present results indicate that some precerebellar neurons sending mossy fibers to the granular layer of the cerebellum use glutamate as excitatory neurotransmitter; glutamate has been reported to exert excitatory influences on most neurons (Krnjevic, 1974) .
It has been suggested that granule cells in the cerebellar cortex use glutamate as a transmitter (Wenthold et al., 1986 ; for further review, see Ito, 1984) . In the present study, however, no evidence suggested the presence of PAG-LI in the granule cells. This is probably because the antibodies are not sensitive enough to detect PAG in the granule cells, or because PAG is not involved in the synthesis of glutamate in granule cells.
